Clinical Trials in Pennsylvania

Showing 19141-19160 of 19,675 trials

Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients

NCT00274313

The purpose of this study is to evaluate the safety and tolerability of a new inhaled sodium-channel blocker called 552-02 in teens and adults with cystic fibrosis. 552-02 will be inhaled once a day for 14 days using a nebulizer. A small subgroup of patients will donate blood samples for pharmacokinetic analysis to see how 552-02 is absorbed into the blood and eliminated after 14 days of treatment.

Cystic Fibrosis

Parion Sciences40 participantsStarted Jan 2006

San Diego, California, United States • San Francisco, California, United States • Denver, Colorado, United States +12 more locations

COMPLETEDPhase 236 miles

Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence

NCT00267930

This study is designed to evaluate the safety, tolerability and preliminary efficacy of vernakalant (oral) in subjects with sustained atrial fibrillation of greater than 72 hours and less than 6 months duration

Atrial Fibrillation

Advanz Pharma221 participantsStarted Dec 2005

Huntsville, Alabama, United States • Walnut Creek, California, United States • Hershey, Pennsylvania, United States +19 more locations

Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients

Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence

Find Trials by Condition in Pennsylvania

CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse

TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery

Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas

Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

Tolerance of Healthy Term Infants Fed Infant Formulas

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Hypertension Screening and Treatment Program

Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Basiliximab in Moderate to Severe Ulcerative Colitis

Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice

Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.

A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin

An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder

An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia